Table 2.

Contraceptive users’ experiences of methods over three months: ordinal variables, sample of family-planning clients using a new contraceptive method for three months (N = 3,762 observations).

	Overall (N = 3,762)	Implant (N = 900)	Copper IUD (N = 572)	LNg IUD (N = 1,198)	Injectable (N = 372)	Oral Contraceptives (N = 574)	Vaginal Ring (N = 146)	p Value and Skillings–Mack Statistic
	%	%	%	%	%	%	%
In the last four weeks, would you say that your birth control method has:								p = .66 (SM = .09)
Made my sex life much worse	2.3	2.8	2.1	2.2	4.0	1.2	1.4
Made my sex life a little worse	12.4	11.2	10.7	15.2	14.8	8.4	13.7
Had no effect on my sex life	33.9	33.8	29.0	30.6	40.1	39.7	43.8
Improved my sex life a little	25.7	24.4	27.6	27.1	19.9	27.0	24.0
Improved my sex life a lot	25.7	27.8	30.6	25.0	21.2	23.7	17.1
Which of the following best describes your vaginal bleeding in the last four weeks?								p < .001 (SM = 81.28)
I’ve had no vaginal bleeding	16.2	22.2	5.9	10.9	41.7	10.3	19.9
I’ve had less bleeding than before	32.4	30.6	12.6	43.3	24.2	38.3	30.1
I’ve had no change from before	13.5	9.9	14.9	7.9	6.2	28.4	34.9
I’ve had more bleeding than before	38.0	37.3	66.6	37.8	28.0	23.0	15.1

Note. Frequencies reflect pooled distributions of variables at one- and three-month follow-up surveys. Data presented are for complete cases in the later regression model, and percentages indicate the column proportion for the specific variable. Descriptive data are presented on the nonimputed original data set. Some columns may add to slightly less than or greater than 100%; these summations are due to rounding errors. P values reflect comparison of outcome by contraceptive methods using the Skillings–Mack statistic, conditional on tied rankings; LNg = levonorgestrel; IUD = intrauterine device.